Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis”

19 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 19 of 19 results

Large-scale testing (Phase 3)Study completedNCT00510484
What this trial is testing

Study Investigating a Delayed-Release Pancrelipase in Patients With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis

Who this might be right for
Cystic Fibrosis
Solvay Pharmaceuticals 35
Testing effectiveness (Phase 2)Study completedNCT05719311
What this trial is testing

Study to Assess an Enteric Microgranule Formulation of Adrulipase in Patients With Cystic Fibrosis

Who this might be right for
Exocrine Pancreatic InsufficiencyCystic Fibrosis
Entero Therapeutics 13
Post-approval studies (Phase 4)WithdrawnNCT04315311
What this trial is testing

Study Of Effects Of Oral CREON Capsules In Adult Participants With Exocrine Pancreatic Insufficiency Not Due To Cystic Fibrosis, Chronic Pancreatitis, Pancreatectomy, Or Pancreatic Cancer

Who this might be right for
Exocrine Pancreatic Insufficiency (EPI)
AbbVie
Not applicableStudy completedNCT05687474
What this trial is testing

Baby Detect : Genomic Newborn Screening

Who this might be right for
Congenital Adrenal HyperplasiaFamilial Hyperinsulinemic Hypoglycemia 1Phosphoglucomutase 1 Deficiency+121 more
Centre Hospitalier Universitaire de Liege 6,824
Testing effectiveness (Phase 2)Study completedNCT01710644
What this trial is testing

Efficacy and Tolerability of NM-BL in Patients With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis

Who this might be right for
Pancreatic InsufficiencyCystic FibrosisDigestive System Diseases+2 more
Nordmark Arzneimittel GmbH & Co. KG 35
Not applicableStudy completedNCT01427725
What this trial is testing

Special Investigation of LipaCreon on Long-term Use in Patients With Pancreatic Exocrine Insufficiency

Who this might be right for
Exocrine Pancreatic InsufficiencyPancreatic DiseasesDigestive System Diseases
Mylan Inc. 579
Large-scale testing (Phase 3)Study completedNCT00690820
What this trial is testing

Study Investigating a Delayed-Release Pancrelipase in Patients With Pancreatic Exocrine Insufficiency (PEI) Due to Cystic Fibrosis (CF)

Who this might be right for
Cystic FibrosisPancreatic Exocrine Insufficiency
Solvay Pharmaceuticals 17
Testing effectiveness (Phase 2)Study completedNCT03746483
What this trial is testing

OPTION: A Trial to Assess the Safety & Efficacy of MS1819 in Patients With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis

Who this might be right for
Exocrine Pancreatic Insufficiency (EPI)Cystic Fibrosis (CF)
Entero Therapeutics 41
Testing effectiveness (Phase 2)Study completedNCT04375878
What this trial is testing

OPTION 2: A Trial to Assess the Safety and Efficacy of MS1819 in Enteric Capsules in Patients With Cystic Fibrosis

Who this might be right for
Exocrine Pancreatic Insufficiency (EPI)Cystic Fibrosis (CF)
Entero Therapeutics 27
Post-approval studies (Phase 4)Study completedNCT02823964
What this trial is testing

EASY: Extended Access to Sollpura Over Years

Who this might be right for
Exocrine Pancreatic InsufficiencyCystic Fibrosis
Anthera Pharmaceuticals 25
Not applicableUnknownNCT03264950
What this trial is testing

Utility of Point Shear-wave Elastography to Assess for Hepatic & Pancreatic Fibrosis in Pediatric CF Patients

Who this might be right for
Cystic FibrosisCystic Fibrosis Liver DiseasePancreatic Insufficiency Due to Cystic Fibrosis of Pancreas
University of Manitoba 60
Not applicableStudy completedNCT01427712
What this trial is testing

Special Investigation (All Cases) of LipaCreon in Patients With Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis

Who this might be right for
Cystic FibrosisExocrine Pancreatic InsufficiencyPancreatic Diseases+1 more
Mylan Inc. 24
Testing effectiveness (Phase 2)Study completedNCT02415959
What this trial is testing

Efficacy and Safety Study of Creon IR in Subjects With Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis

Who this might be right for
Exocrine Pancreatic Insufficiency in Subjects With Cystic Fibrosis
Abbott 70
Large-scale testing (Phase 3)Study completedNCT01747330
What this trial is testing

Evaluation of Safety and Tolerability of Creon Micro in Children Younger Than Four Years With Pancreatic Exocrine Insufficiency

Who this might be right for
Pancreatic Exocrine Insufficiency
Abbott Products 40
Early research (Phase 1)Study completedNCT06052293
What this trial is testing

Phase 1 Study to Assess Safety and Efficacy of ANG003

Who this might be right for
Exocrine Pancreatic Insufficiency
Anagram Therapeutics, Inc. 57
Large-scale testing (Phase 3)Study completedNCT00775528
What this trial is testing

Study Investigating a Delayed-Release Pancrelipase in Patients With Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis

Who this might be right for
Cystic FibrosisPancreatic Exocrine Insufficiency
Solvay Pharmaceuticals 19
Testing effectiveness (Phase 2)Looking for participantsNCT07450547
What this trial is testing

Phase 2 Study to Assess the Safety and Efficacy of ANG003

Who this might be right for
Exocrine Pancreatic Insufficiency (EPI)Cystic Fibrosis (CF)
Anagram Therapeutics, Inc. 113
Post-approval studies (Phase 4)Study completedNCT03924947
What this trial is testing

Compare US Marketed Creon Manufactured With a Modernized Process at an Alternate Manufacturing Site and Manufactured With the Approved Manufacturing Process at an Alternate Active Pharmaceutical Ingredient Site, in Participants With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis

Who this might be right for
Cystic Fibrosis
AbbVie 36
Large-scale testing (Phase 3)Study completedNCT02137382
What this trial is testing

A Double-blind, Randomized, Multicenter, Cross-over Study to Compare the Effect of Creon N and Creon® on Fat Digestion in Subjects ≥ 12 Years of Age With Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis

Who this might be right for
Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis
Abbott 41